– Published Feb. 12, 2023
Dr. Ranjit Bindra is a physician-scientist at the Yale School of Medicine, the Harvey and Kate Cushing Professor of Therapeutic Radiology, and the Scientific Director of the Yale Brain Tumor Center. Clinically, he treats adult and pediatric primary CNS cancers, as well as brain metastases using radiosurgery.
As an active biotech entrepreneur, he has founded five companies based on work from his laboratory, including Cybrexa Therapeutics, Alphina Therapeutics, and Modifi Bio.
Dr. Bindra received his undergraduate degree in Molecular Biophysics and Biochemistry from Yale University in 1998, and both his MD and PhD from the Yale School of Medicine in 2007. He completed his medical internship, radiation oncology residency, and post-doctoral research studies at the Memorial Sloan-Kettering Cancer Center (MSKCC) in 2012.
In this episode, we talk about being a scientist and doctor while also pursuing entrepreneurship at the same time, the pipeline for creating startups from the lab to the market, and thoughts on being in academia vs business.